Skip to search.
 TSX Up 0.15% TSX Ventures Down 0.75%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
13.40 Down 0.17(1.25%) Aug 4, 4:00PM EDT
Add to Portfolio
Prev Close:13.57
Open:13.68
Bid:13.35 x 300
Ask:13.70 x 1000
1y Target Est:13.25
Beta:0.19
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:13.06 - 13.79
52wk Range:2.31 - 14.40
Volume:2,946,698
Avg Vol (3m):3,382,820
Market Cap:1.72B
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ZIOPDown 1.25%1.72B
IMGNDown 1.80%1.41B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,203.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.70
Quarterly EPS Est (Jun-15) :-0.22
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback